A British doctor who tested positive for Ebola while working on the outbreak in the Democratic Republic of the Congo has been flown back to the United Kingdom and is being treated in a high-level isolation unit at the Royal Free Hospital in London. The patient arrived on Thursday, the UK government said, in the first case involving a British national in the current outbreak.

The doctor, who has not been named, had been sent to DR Congo by a humanitarian organisation to help with the response to the outbreak, which the country's health ministry declared on 15 May and which has since become the second-largest Ebola outbreak on record. According to Reuters, the patient was in a stable condition before the evacuation.

The journey home

The doctor was brought home on a medical evacuation flight arranged after the positive test, the Department of Health and Social Care said on Thursday. The flight landed at RAF Northolt, a military airbase in west London, and the patient was then transferred by ambulance to the hospital under a carefully planned escort designed to keep the journey fully contained.

The transfer was a large and highly visible operation. A convoy of emergency vehicles carried the patient from the airbase to the hospital, with three large police vans travelling at either end of the group, alongside two ambulances and a support car. Traffic was stopped along the route, and police officers stepped out of their vehicles to keep members of the public away as the convoy arrived at the hospital entrance.

Inside the Royal Free, in Hampstead, north London, the patient is being treated in a specialist isolation unit with strict protocols in place to prevent any contact with members of the public. All staff treating the patient are equipped with the necessary personal protective equipment, alongside other measures designed to prevent transmission.

The evacuation was a joint effort between the governments of the UK and DR Congo and international health partners, the government said. The Royal Free's unit is one of a small number in England set up to handle high-consequence infections, and the hospital has direct experience of this disease: it successfully treated three health workers who were evacuated to London after the Ebola outbreak in West Africa in 2014 and 2015.

Reassurance on risk to the public

Officials moved quickly to reassure the public that the risk from the case is limited. Dr Renu Bindra, deputy director for all-hazards public health response at the UK Health Security Agency, said the agency and the NHS have well-established and robust infection prevention and control protocols to limit the risk of onward transmission, and that the risk to the wider public remains low.

"UKHSA and the NHS have well-established and robust infection prevention and control protocols to limit the risk of onward transmission, and the risk to the wider public remains low." — Dr Renu Bindra, UK Health Security Agency

A UK government spokesperson had given the same message earlier in the week, saying there were well-established procedures for dealing with cases like this. British authorities also told Reuters they did not expect the case to have a serious public health impact in Britain, and anticipated no disruption to international travel or trade.

Ebola cases in the UK are extremely rare. Only four cases of the virus have been confirmed in the country previously since 1976, according to the UK Health Security Agency. One, in 1976, resulted from a laboratory needle incident, and the other three involved health workers who had been responding to the outbreak in West Africa between 2014 and 2015. None of those earlier cases resulted in a death, and each patient was treated in isolation under similar precautions.

An outbreak still growing

The outbreak the doctor was helping to fight has passed 10,000 confirmed cases and more than 5,000 deaths, according to figures reported in late October, making it the second largest and second most deadly Ebola outbreak on record, behind only the West Africa outbreak of the 2010s. Figures reported at the end of last month put the fatality rate for the current outbreak at 48.6 percent, a reminder of how severe the disease remains even with modern care.

The outbreak has not stayed within DR Congo's borders. It has spread to Kenya and Uganda in east Africa, and last month Nigeria confirmed a case in its capital, Abuja. The spread across borders has added to the challenge facing health teams, who must track contacts and contain transmission in several countries at once while the outbreak continues to grow.

On 20 October, Nigeria confirmed its first case of Ebola disease in the current outbreak after laboratory tests detected the Bundibugyo virus in a woman who had travelled to the country from Uganda. According to the World Health Organization, the patient developed symptoms on 7 October, four days after arriving in Nigeria, and sought medical attention at a private health facility in Abuja on 11 October. The laboratory confirmation made Nigeria the fifth country to detect the virus since the outbreak was declared in DR Congo on 15 May. The patient was subsequently evacuated to Switzerland on 26 October for further medical care, alongside her husband, who was identified as a close contact.

The outbreak is being fuelled by the Bundibugyo variant of the virus, one of the strains that causes Ebola disease. There is currently no approved vaccine against this variant, but the World Health Organization has said experts have recommended adding two new candidate vaccines to an ongoing clinical trial, and vaccines designed specifically against Bundibugyo are now being prepared for testing. One was developed by the University of Oxford and the Serum Institute of India, and another by the firm Moderna, and both will join the trial once they are approved by Congolese health authorities. It will be the first time vaccines specifically designed to protect against the Bundibugyo virus are tested during an outbreak.

DateDevelopment
15 May 2026DR Congo's health ministry declares the Ebola outbreak
20 October 2026Nigeria confirms its first case — a woman who travelled from Uganda; the fifth country to detect the virus
26 October 2026Nigeria's patient is evacuated to Switzerland for further care
4 November 2026WHO approves clinical trials for two new vaccines designed against the Bundibugyo variant
5 November 2026British doctor evacuated from DR Congo arrives in London and is admitted to the Royal Free Hospital

What is not yet known: the patient's identity has not been disclosed, and no further update on their condition has been published. There is still no approved vaccine against the Bundibugyo variant — the two candidate vaccines are entering trials, not yet in general use. The UK Health Security Agency has said the risk to the wider public remains low.

Frequently asked questions

Is there a risk to the UK public?

According to the UK Health Security Agency, the risk to the wider public remains low. Ebola spreads through direct contact with the body fluids of infected people, such as blood or vomit, or with dead bodies — not through the air — and the patient is being treated in a high-level isolation unit with strict protocols to prevent contact with members of the public.

How does Ebola spread?

Ebola is a highly contagious, severe and often fatal illness. It spreads through direct contact with the body fluids of infected people, or with dead bodies, which means that health workers and family members caring for the sick face the greatest risk. People with the disease tend to fall ill between two and 21 days after contact with the virus, and the first signs are often fever, aches, pains and fatigue. The illness can then progress to much more serious symptoms, including diarrhoea, vomiting and unexplained bleeding, and in severe cases it can lead to organ failure and internal bleeding.

What is the Bundibugyo variant?

Bundibugyo is one of the strains of virus that causes Ebola disease, and it is the strain fuelling the current outbreak. There is currently no approved vaccine against this variant, although two candidate vaccines designed specifically against it — one from the University of Oxford and the Serum Institute of India, another from Moderna — are being prepared for testing in an ongoing clinical trial.

Why was the doctor flown to London?

The Royal Free Hospital in London has a high-level isolation unit specifically designed for high-consequence infectious diseases such as Ebola, staffed by expert clinical teams. It has treated Ebola patients before, including three health workers evacuated from West Africa in 2014 and 2015. The evacuation was arranged jointly by the UK and DR Congo governments and international health partners.

How big is the outbreak?

Figures reported in late October put the outbreak at more than 10,000 confirmed cases and more than 5,000 deaths, making it the second-largest Ebola outbreak on record. It has spread beyond DR Congo to Kenya, Uganda and Nigeria, and the fatality rate was reported at 48.6 percent at the end of last month.

Key takeaways

  • A British doctor who caught Ebola while working on the response in DR Congo has been flown to London and is being treated in isolation at the Royal Free Hospital.
  • The patient arrived on Thursday after a medical evacuation flight landed at RAF Northolt, and was transferred to hospital in a police-escorted convoy.
  • It is the first case involving a British national in the current outbreak; the patient was reported to be in a stable condition before the evacuation.
  • The UK Health Security Agency says the risk to the wider public remains low, and only four Ebola cases have ever been confirmed in the UK before.
  • The outbreak has passed 10,000 cases and more than 5,000 deaths, and has spread to Kenya, Uganda and Nigeria; two new vaccines designed against the Bundibugyo variant are entering trials.

What to watch next: updates from the UK Health Security Agency and the Royal Free Hospital on the patient's condition; whether Congolese health authorities approve the two new Bundibugyo vaccines for the ongoing trial; and the next official figures from the outbreak, which health teams are tracking across DR Congo, Kenya, Uganda and Nigeria.